One 'oversold' ASX 200 healthcare share to buy today

After some big share price falls, is this ASX 200 healthcare stock trading for a bargain?

| More on:
Smiling couple looking at a phone at a bargain opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) healthcare share Ramsay Health Care Ltd (ASX: RHC) is in the green today following two trading days of heavy selling.

In afternoon trade on Tuesday, the Ramsay share price is up 0.5% at $40.58 a share.

That will come as welcome news to shareholders after the ASX 200 healthcare share closed down a precipitous 6.8% on Friday following the release of its full-year results.

That decline, however, looks to reinforce Shaw and Partners' Jed Richards' buy recommendation for Ramsay Health Care (courtesy of The Bull).

Why Ramsay shares could be bargain-priced

"Ramsay is Australia's biggest private hospital operator. It also operates in the UK and Europe," Richards explains.

He noted that the ASX 200 healthcare share had tumbled from $56.47 on 6 March to trade for $44.42 a share on 29 August. And shares have since declined to the current $40.58.

According to Richards:

In our view, the shares have been oversold. The company had a market capitalisation of more than $10 billion on 29 August. The company is well managed, and we expect RHC to improve in fiscal year 2025.

What's been happening with the ASX 200 healthcare share?

As mentioned up top, Ramsay reported its FY 2024 financial results on Friday, 30 August.

And those results revealed a difficult year for the private hospital operator.

While total revenue increased 9.4% year on year to $16.77 billion, earnings before interest and tax (EBIT from continuing operations) went the other direction, falling 0.4% to $998 million.

And feeling the impacts of cost inflation, the ASX 200 healthcare share reported a 2.6% decline in profit after tax from continuing operations, which came in at $271 million.

Despite the dip in profits, management pleased passive income investors with a final dividend of 40 cents per share, fully franked. That's up 60% from the prior final dividend. And it brings the full-year passive income payout to 80 cents per share.

This sees Ramsay shares trading on a fully franked dividend yield of 2.0%. And if you're looking to bag that final dividend, you'd best hurry. Ramsay shares trade ex-dividend tomorrow, 4 September. Meaning you'll need to own shares at market close today to have rights to that payout.

Eligible investors can then expect to see that passive income hit their bank account on 26 September.

Looking to the year ahead, the ASX 200 healthcare share forecasts growth in its net profit after tax from continuing operations in FY 2025. Though margin recovery is expected to be slow, impacted by ongoing inflationary pressures and investments in business enablement programs.

The Ramsay share price is down 24% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Why are Mesoblast shares jumping 10% to a 52-week high?

This biotech is hitting new highs on Friday. Let's find out why.

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Ansell shares tumble to a 3-month low. Is this a buying opportunity?

Ansell shares have slid to a 3-month low. Could oversold signals point to a buying opportunity for long-term investors?

Read more »

Female scientist working in a laboratory.
Healthcare Shares

These three biotechs show how the sector can produce huge outsized gains, but are they still good value?

These drug developers' shares are trading near 12-month highs.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

This biotech is approaching 20-bagger status within a year and the good news continues to come

This company has just won approval to go ahead with a key clinical trial.

Read more »

An investor sits at a table in front of her laptop with a party hat on her head and a cake next to her symbolising new year's eve but the 4DS Memory share price is plunging so she looks very disappointed and depressed
Healthcare Shares

$5 billion ASX 200 healthcare stock tumbling on CEO exit

Investors are bidding down the ASX 200 healthcare giant on Thursday. Let’s see why.

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »